PT
Pelthos Therapeutics Inc. (PTHS)
AMEX·Healthcare·Biotechnology
$27.68
+2.33%
Mkt Cap $15.45M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$60.50
Range $55.00 – $66.00
Implied Upside
+118.6%
Consensus $60.50 vs current $27.68
AMEX·Healthcare·Biotechnology
$27.68
+2.33%
Mkt Cap $15.45M
No recent rating data.
Price Target (7 analysts)
$60.50
Range $55.00 – $66.00
+118.6%
Consensus $60.50 vs current $27.68